Skip to main content

RETRACTION article

Front. Pharmacol., 06 July 2023
Sec. Cardiovascular and Smooth Muscle Pharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1247749

Retraction: Curcumin improves palmitate-induced insulin resistance in human umbilical vein endothelial cells by maintaining proteostasis in endoplasmic reticulum

This article is a retraction of:

  1. RETRACTED: Curcumin Improves Palmitate-Induced Insulin Resistance in Human Umbilical Vein Endothelial Cells by Maintaining Proteostasis in Endoplasmic Reticulum

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research
Curcumin improves palmitate-induced insulin resistance in human umbilical vein endothelial cells by maintaining proteostasis in endoplasmic reticulum

by Ye M, Qiu H, Cao Y, Zhang M, Mi Y, Yu J and Wang C (2017). Front. Pharmacol. 8:148. doi: 10.3389/fphar.2017.00148

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

The authors agree to this retraction.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers.

Citation: Frontiers Editorial Office (2023) Retraction: Curcumin improves palmitate-induced insulin resistance in human umbilical vein endothelial cells by maintaining proteostasis in endoplasmic reticulum. Front. Pharmacol. 14:1247749. doi: 10.3389/fphar.2023.1247749

Received: 26 June 2023; Accepted: 26 June 2023;
Published: 06 July 2023.

Approved by:

Eliot Ohlstein, Drexel University, United States

Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.